Results 71 to 80 of about 110,265 (199)

Visualizing mitochondrial FoF1-ATP synthase as the target of the immunomodulatory drug Bz-423

, 2018
Targeting the mitochondrial enzyme FoF1-ATP synthase and modulating its catalytic activities with small molecules is a promising new approach for treatment of autoimmune diseases. The immuno-modulatory compound Bz-423 is such a drug that binds to subunit
Börsch, Michael, Glick, Gary D., Starke, Ilka   +2 more
core   +1 more source

Requests for malaria prevention advice to Public Health England, Malaria Reference Laboratory: a retrospective observational study.

, 2013
BACKGROUND: The Malaria Reference Laboratory (MRL) provides a specialist advisory service for complex queries from healthcare professionals. This study was conducted to examine the types of queries that general practitioners and nurses ask around malaria
Blaze, Marie, Chiodini, Peter L, Godbole, Gauri, Smith, Valerie, Whitty, Christopher JM   +4 more
core   +1 more source

Human-centred design methods : developing scenarios for robot assisted play informed by user panels and field trials [PDF]

, 2010
Original article can be found at: http://www.sciencedirect.com/ Copyright ElsevierThis article describes the user-centred development of play scenarios for robot assisted play, as part of the multidisciplinary IROMEC1 project that develops a novel ...
Caprino, F., Dautenhahn, K., Ferrari, E., Gelderblom, G., Kronreif, G., Laudanna, E., Marti, P., Prazak-Aram, B., Robins, B., Tanja, B.   +9 more
core   +1 more source

Left ventricular assist device infections: From epidemiology to treatment

JHLT Open
Background: Infections are among the most frequent and severe complications in patients supported with left ventricular assist devices (LVADs), significantly affecting morbidity, mortality, and transplant candidacy.
Marta Hernández-Meneses, Elena Sandoval, Marta Farrero   +2 more
doaj   +1 more source

Left Ventricular Assist Devices – Past, Present, and Future: A Narrative Review

Journal of the Practice of Cardiovascular Sciences
Advanced heart failure (AHF) is a major problem with an aging population and profound unmet needs. While heart transplant offers the most definitive solution, it is largely unavailable for most and mandates a long waiting period.
Devesh Kumar, Sandeep Seth, Rajiv Narang
doaj   +1 more source

Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach

Journal of Cardiothoracic Surgery, 2012
Left Ventricular Assist Device (LVAD) for Destination Therapy (DT) is an established therapy for end stage heart failure patients who are not transplant candidates.
Samuels Louis E, Casanova-Ghosh Elena, Rodriguez Roberto, Droogan Christopher   +3 more
doaj   +1 more source

Uncovering How Occupational Therapy Could Benefit Individuals Living with Sickle Cell Disease in Ghana [PDF]

, 2018
In 2017, with funding from a Summer Undergraduate Research Fellowship (SURF), I spent ten weeks in Kumasi, Ghana conducting research on how occupational therapy may be beneficial for individuals living with sickle cell disease.
D\u27Olympio, Carolyn
core   +1 more source

The Ventricular Assist Device team in the management of patients treated with long-term Mechanical Circulatory Support

Infermieristica Journal
The number of people with heart failure is increasing rapidly worldwide. Despite preventive measures, optimal medical therapy, and cardiac transplantation, the overall morbidity and mortality of this syndrome remain high.
Simone Amato, Andrea Battisti, Daniele Napolitano   +2 more
doaj   +1 more source

Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry. [PDF]

ESC Heart Fail, 2023
Dobarro D, Donoso-Trenado V, Solé-González E, Moliner-Abós C, Garcia-Pinilla JM, Lopez-Fernandez S, Ruiz-Bustillo S, Diez-Lopez C, Castrodeza J, Méndez-Fernández AB, Vaqueriza-Cubillo D, Cobo-Marcos M, Tobar J, Sagasti-Aboitiz I, Rodriguez M, Escolar V, Abecia A, Codina P, Gómez-Otero I, Pastor F, Marzoa-Rivas R, González-Babarro E, de Juan-Baguda J, Melendo-Viu M, de Frutos F, Gonzalez-Costello J.   +25 more
europepmc   +1 more source

Recent change in bridging strategy and improved clinical outcomes following durable left ventricular assist device implantation in Japan

JHLT Open
Background: Destination therapy (DT) was approved in Japan in May 2021. Use of Impella device as a bridge to left ventricular assist device (LVAD) implantation has been increasing.
Makiko Nakamura, Teruhiko Imamura, Yoshikatsu Saiki, Minoru Ono, Koichiro Kinugawa   +4 more
doaj   +1 more source